Zhonghua zhongliu zazhi
BioMed Central
About the journal
Zhonghua zhongliu zazhi is a journal published by BioMed Central in China. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BioMed Central
- ISSN
- 0253-3766
- Country
- China
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
Index listings
- MEDLINE · 1979-01-01
- PUBMED · 2014-12-23
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
596
Last recorded publication year
2021
h-index
3
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy(no data)
No data available to the platform for this group
Identity & continuity3
- Alternate titles
- Chinese Journal of Oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 7910681
Classification(no data)
No data available to the platform for this group
No platform data for: Editorial & policy · Classification — absence is not a judgment about the journal.
Subject areas
- Legal and Regulatory Analysis
- Legal and Regulatory Analysis
- Linguistic, Cultural, and Literary Studies
- Linguistic, Cultural, and Literary Studies
- Military Technology and Strategies
- Military Technology and Strategies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastric Cancer Management and Outcomes
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Medical Research and Treatments
- Medical Research and Treatments
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Cancer-related gene regulation
- MRI in cancer diagnosis
- Cancer-related gene regulation
- MRI in cancer diagnosis
- Cancer Immunotherapy and Biomarkers
- Lymphoma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lymphoma Diagnosis and Treatment
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ